Navigation Links
GenVec Presents Research on New Ad35 Adenovector at ARVO

GAITHERSBURG, Md.--(BUSINESS WIRE)--May 10, 2007 - GenVec, Inc. (Nasdaq:GNVC) today announced pre-clinical research demonstrating the ability of the Company's new adenovector, Ad35, to induce and sustain protein production in the eye. Lisa L. Wei, Ph.D., GenVec's Director of Pre-Clinical Research, presented a poster, Alternate Serotype Adenovector Gives Long-Term Expression in the Eye, at the Association for Research in Vision and Ophthalmology ("ARVO") Annual Meeting in Fort Lauderdale, Florida.

Currently available treatments for ocular neovascular diseases such as wet age-related macular degeneration (AMD) involve intravitreal injections to the eye. Both patients and doctors desire less frequent injections into the eye to deliver such therapeutics. A possible strategy is the use of gene delivery systems to achieve sustained production of therapeutic proteins in the eye over a period of several months.

GenVec researchers compared the duration of expression in the eye of two different adenovectors, Ad5 and Ad35. The results showed sustained protein expression beyond 4 months in eyes treated with the Ad35 vector. With the Ad5 vector, expression diminished substantially by day 7. These results indicate that changes in the adenovector can lead to potentially important advantages in the delivery of proteins. In the case of AMD, less frequent drug administration would be of clear benefit to patients.

"It is now clear that delivery of anti-angiogenic agents to the eye can be effective in treating AMD by blocking abnormal blood vessel formation," stated Dr. Wei. "Our studies reported today demonstrated delivery of PEDF, a potent factor capable of both blocking and reversing animal models of AMD. We believe that sustained delivery of other therapeutic proteins to the eye should be possible using this technology."

About AMD

AMD affects almost thirty percent of adults between the ages of 75 an
'"/>




Page: 1 2 3

Related medicine technology :

1. GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade at ASCO
2. GenVec Announces New Research at AACR on Selectivity and Mechanism of Action of TNF-Based Anti-Cancer Therapy
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: GenVec Presents Research New Adenovector ARVO
(Date:5/4/2015)... TORONTO , May 4, 2015 ... that it intends to dividend to its stockholders a ... a definitive licensing agreement to license its RapidMist™ buccal ... (OTCQB:SMFI). As announced on April 23, 2015, ... respect of the licensing of its RapidMist™ buccal drug ...
(Date:5/4/2015)... May 4, 2015 Rogne Bioscience, a privately-held ... announced that preclinical and mechanism of action data will ... of Investigative Dermatology (SID) Annual Meeting being held May ... Atlanta, Georgia . Logo - http://photos.prnewswire.com/prnh/20150501/213318LOGO ... of RON2315, a novel, low MW (<1700 daltons) peptide ...
(Date:5/4/2015)... May 4, 2015   HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of advanced ... Godshall , is scheduled to present at the Bank of ... Las Vegas on Thursday, May 14, 2015, at ... webcast of the Company,s presentation at the conference will be ...
Breaking Medicine Technology:Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 3Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 4Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 5Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2
... , REDWOOD CITY, Calif., Dec. 24 Maxygen, ... the development of improved versions of protein drugs, today announced ... which expired at 5:00 p.m., New York City time, on ... count by the depositary for the tender offer, Maxygen expects ...
... , , WINNIPEG, Manitoba, Dec. 23 On Dec. ... wholesale reimportation of cheaper prescriptions drugs from abroad, despite projected ... prescription for Americans. , "Americans are still paying up ... Australia, the UK, New Zealand and India," said Gary Ryan, ...
Cached Medicine Technology:Maxygen, Inc. Announces Preliminary Results of Dutch Auction Tender Offer 2Obama Plan Buckles Under Pharma Lobby; Plan to Import Low-Cost Medicines Derails 2Obama Plan Buckles Under Pharma Lobby; Plan to Import Low-Cost Medicines Derails 3
(Date:5/4/2015)... (PRWEB) May 04, 2015 Takeda Pharmaceuticals ... billion to settle thousands of Actos lawsuits ( http://www.theactoslawsuitcenter.com/ ... increases the risk that a patient will develop bladder ... 28th, if 95% of those eligible for the Actos ... 9,000 bladder cancer cases currently pending in courts around ...
(Date:5/4/2015)... “ LiveSchool ” was featured on NewsWatch ... look at the latest and coolest applications on the ... host of AppWatch and technology expert, conducted the app ... teachers to reward students with good behavior. , Positive ... the classroom. And the good people at LiveSchool ...
(Date:5/4/2015)... 04, 2015 Baptist Medical Center ... Association’s Get With The Guidelines®-Stroke Gold Plus Quality ... Roll. The award recognizes the hospital’s commitment and ... most appropriate treatment according to nationally recognized, research-based ... To receive the Gold Plus Quality Achievement Award, ...
(Date:5/4/2015)... 2015 Ticket Down is a reputable source ... (ICC) . While the World Cup is the most ... four years, the International Champions Cup is one of the ... all-time attendance record for soccer in the United States set ... at the University of Michigan. This year, the defending champion ...
(Date:5/4/2015)... 2015 Ticket Down is a reputable source ... Arena in Columbia, South Carolina. Fans of Paul ... “Out There” tour which originally kicked off in 2013. The ... America and the legendary performer recently announced that he would ... Arena on June 21st, in Charlottesville, VA at John Paul ...
Breaking Medicine News(10 mins):Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 4Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2
... a number of studies have suggested that regular exercise reduces ... and other diseases, such as diabetes its still not ... a link exists, the nature of the relationship is by ... kinesiology and community health researchers at the University of Illinois ...
... underway today when External Affairs Minister Pranab Mukherjee inaugurated ... ,The project is the direct outcome ... in 2004 during the inaugural session of the Pan-African ... said: "We have a long tradition of co-operation between ...
... healthcare has been rapid. A growing number of patients ... they receive. These 'power patients' possess characteristics that distinguish ... in driving the use of the Internet in healthcare. ... treatments received, access to quality information about their care ...
... giant pharmaceutical firm is close to developing the world's first ... battle outbreaks, a news report said Friday. ,Clinical ... next year in Thailand, said Jean Stephenne, GlaxoSmithKline Biologicals president. ... the US Army for 10 years, more or less," The ...
... India making its presence felt on the world fashion ... only eager to walk the ramp here but also ... the years Indian fashion matured as designers stopped copying ... innovative silhouettes as well as becoming a profitable business ...
... expression with the disease process that lies behind chronic fatigue ... blood may hold key information about what goes on in ... by severe, chronic mental and physical exhaustion, arising in a ... conducted by a team of researchers led by Professor Andrew ...
Cached Medicine News:Health News:Exercise Reduces Inflammation 2Health News:Exercise Reduces Inflammation 3Health News:Exercise Reduces Inflammation 4Health News:Mukherjee Inaugurates Tele-education and Tele-medicine Centres in Addis Ababa 2Health News:Benefits From the Use of the Internet in Healthcare Applications Highlighted 2Health News:Benefits From the Use of the Internet in Healthcare Applications Highlighted 3Health News:Indian Fashion Beckons International Models 2
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: